Mode
Text Size
Log in / Sign up

Feijoa powder supplementation did not improve weight or glucose but lowered systolic blood pressure in adults with prediabetes.

Feijoa powder supplementation did not improve weight or glucose but lowered systolic blood pressure …
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider that feijoa powder may enhance blood pressure reduction in adults with prediabetes, though safety data are lacking.

This randomized controlled trial investigated the effects of whole fruit feijoa powder supplementation in adults with overweight and prediabetes. A total of 97 participants were enrolled, with 48 assigned to the feijoa powder group and 49 to the placebo group. All participants followed a low-energy diet for 6 months. The primary outcomes assessed were fasting plasma glucose and body weight, while secondary outcomes included systolic and diastolic blood pressure.

Regarding body weight and glucose, both groups demonstrated a significant decrease during the initial 2-month low-energy diet period, with a gradual upward trajectory observed over the subsequent 4 months. There was no significant difference in body weight or fasting plasma glucose between the feijoa powder and placebo groups over the 6-month follow-up period (treatment-by-time interaction P=0.74 for weight; P=0.09 for glucose).

In contrast, systolic blood pressure declined significantly over 6 months between treatments. Systolic blood pressure in the feijoa group was lower than in the placebo group at months 4 and 6 (treatment-by-time interaction P=0.01). Diastolic blood pressure did not decline significantly between the two treatment groups. No adverse events, serious adverse events, discontinuations, or specific tolerability data were reported in the study.

The study had limitations, including the use of imputation for missing not-at-random data points. Given the lack of reported safety data and the observational nature of the blood pressure findings within a controlled setting, the results should be interpreted with caution. Feijoa powder supplementation may enhance blood pressure improvement achieved through weight loss in adults with overweight and prediabetes, but further research is needed to confirm safety and efficacy.

Study Details

Study typeRct
Sample sizen = 48
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BackgroundLow energy diets (LEDs) are effective for body weight (BW) loss and improvement of type 2 diabetes (T2D) risk biomarkers. Emerging evidence suggests that whole fruit feijoa powder, rich in polyphenols and abscisic acid, may further support T2D prevention. The FERDINAND study investigated whether daily consumption of a whole fruit feijoa powder enhanced LED-driven improvements in fasting plasma glucose (FPG), BW, and other metabolic markers. MethodsAt in-clinic screening, 97 participants were enrolled into the trial and randomised to receive 1.15 g/day of whole fruit feijoa powder (Fx, n=48) or Placebo treatment (n=49) for 6 months. All participants underwent 2 months of LED-induced weight loss, followed by 4 months of dietary advice for weight loss maintenance. BW, FPG, and secondary outcomes including blood pressure (BP), were assessed at baseline (M0), end of month 2 (M2), 4 (M4), and 6 (M6). Data were analysed using linear mixed-effects models as intention-to-treat (ITT) with imputation for missing not-at-random data points. ResultsBW significantly decreased in both treatment groups during the 2 month LED, with a gradual upward trajectory over the subsequent 4 months (time0-6m: P<0.001). There was no difference in BW between Fx and Placebo over the 6 month intervention (treatmentxtime0-6m: P=0.74). FPG followed the weight loss trajectory in both treatment groups (time0-6m: P<0.001), but with no significant between-group interaction over 6 months (treatmentxtime0-6m: P=0.09, n=97). Systolic BP (SBP), but not diastolic BP, declined significantly over the 6 months between treatments (treatmentxtime0-6m: P=0.01) in all participants, with SBP in Fx lower than Placebo at M4 and M6 (P<0.05, both). ConclusionsIn adults with overweight and prediabetes, Fx supplementation may enhance blood pressure improvement achieved through BW loss. The polyphenolic matrix of whole fruit feijoa, which contains a high proportion of catechins, may have contributed to vascular benefits.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.